Vaccination Archives - Infectious Disease Advisor

elderly man receiving vaccine, injection, influenza

Methotrexate Discontinuation May Improve Influenza Vaccine Response During the COVID-19 Pandemic

By

Emily Pond

January 29, 2021

Study authors evaluated the effects of methotrexate discontinuation on influenza vaccine response during the COVID-19 pandemic.

COVID19

COVID-19 Variants: Pfizer, Moderna Updates, and IDSA Media Briefing

By

Chen Fang, PharmD, RPh

January 27, 2021

Moderna and Pfizer provide updates on mRNA vaccines against variant B.1.1.7; Infectious Diseases Society of America holds media briefing on COVID-19 variants.

COVID19

FDA Urges HCPs to Follow Authorized Dosing Schedules for COVID-19 Vaccines

By

Diana Ernst, RPh

January 27, 2021

Additional research from the vaccine manufacturers would be needed to support any changes to the dosing schedule.

COVID19

Moderna COVID-19 Vaccine Shows High Efficacy, Low Risk for Adverse Events

By

Jessica Nye, PhD

January 25, 2021

The mRNA-1273 vaccine, developed by Moderna and the NIH, was evaluated for its efficacy in preventing COVID-19 illness with onset at least 14 days after the second injection.

General Infectious Disease

Typhoid Fever in US Children: Vaccination Low and Antimicrobial-Resistant Infections Common

By

Sweta Gupta

January 13, 2021

Investigators explored the implications of updated vaccination strategies for typhoid fever targeting younger at-risk children in the United States.

COVID19

FDA Advisory Committee OKs Pfizer-BioNTech COVID-19 Vaccine

December 18, 2020

The U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee today voted to recommend emergency use authorization.

COVID19

Regaining Public Trust in Science: Conversation With Dr Fauci

By

Chen Fang, PharmD, RPh

December 1, 2020

Anthony Fauci, MD, discusses public trust in science, vaccine progress, and vaccine facilitation as the United States heads toward a new phase of the pandemic.

The approval is based on evidence that the vaccine can prevent anogenital infections, with an ongoing trial looking at throat infection prevention in men likely to be critical for continued approval.

Influenza

Influenza Vaccination Does Not Increase Risk for Guillain-Barré Syndrome

By

Zahra Masoud

December 1, 2020

Study authors identified and evaluated a statistical signal for an increased risk of Guillain-Barré Syndrome in days 1-42 after 2018-2019 high-dose influenza vaccine administration.

COVID19

Interim Data Show COVID-19 Vaccine Candidate mRNA-1273 Near 95% Effective

By

Diana Ernst, RPh

November 17, 2020

The placebo-controlled COVE study is investigating the efficacy and safety of mRNA-1273 at the 100mcg dose (given intramuscularly in a 2-dose series, approximately 28 days apart) in more than 30,000 adults aged 18 years and older.

General Infectious Disease

Lower Measles and Mumps Seroprotection in Cancer Patients

By

Zahra Masoud

November 10, 2020

Study authors measured seroprevalence of measles and mumps among cancer patients and compared seroprevalence based on demographic, disease, and treatment subgroups.